When was 23Mofang founded?

23Mofang was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is 23Mofang located?

23Mofang is headquartered in Chengdu, China.

Is 23Mofang a funded company?

23Mofang is a funded company, having raised a total of $34.3M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 2016.

When was the latest funding round of 23Mofang?

23Mofang's latest funding was a $***** Series B round on May 31, 2018, with participation from 4 investors.

Where does 23Mofang rank among its competitors?

23Mofang ranks 2nd amongst 10 active competitors, of which 6 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was CircleDNA, which secured $15M in Sep, 2020.

Who are the top competitors of 23Mofang?

23Mofang's top competitors include CircleDNA, WeGene and LeGENE. Among them, CircleDNA secured the most recent funding round in September, 2020.

23Mofang - 2026 Company Profile, Funding & Competitors

Company Details

23Mofang provide users genetic testing services to help prevent potential problems and early intervention. They also allow users to better understand and be aware awareness of their health risks and physical characteristics. It claims to follow strict international standard quality control system and integration of global research data for the interpretation of the genetic code.

Key Metrics

Founded Year

2015

Location

Chengdu, China

Stage

Series B

Total Funding

$34.3M in 5 rounds

Latest Funding Round

Series B, May 31, 2018, $*****

Investors

Matrix Partners China & 9 more

Ranked

2^nd among 10 active competitors

Similar Companies

OpenEvidence & 2670 more

View 23Mofang's full profile

23Mofang has raised a total funding of $34.3M over 5 rounds. Its first funding round was on Jan 2016. Its latest funding round was a Series B round on May 31, 2018 for $*****. 4 investors participated in its latest round. 23Mofang has 10 institutional investors.

Here is the list of recent funding rounds of 23Mofang:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 31, 2018	7623431	Series B	2870243	9315334	2428324	3225504
Mar 06, 2018	4043386	Series B	8276636	3354766	8888922	Deshang & 1 more
Aug 02, 2017	9131576	Series B	1192204	4836494	Hanwang	Chengdu Deshang Maker Equity Investment Fund Management & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of 23Mofang's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of 23Mofang include CircleDNA, WeGene and LeGENE. Here is the list of Top 10 competitors of 23Mofang, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CircleDNA 2014, Hong Kong (China), Series B	Provider of internet first diagnostics platform for genetic tests	$60M	Apis Partners, Alibaba Entrepreneurs Fund	47/100
2nd	23Mofang 2015, Chengdu (China), Series B	Provides genetic testing services to help prevent potential problems and early intervention.	$34.3M	SBCVC, 3E Bioventures Capital & 8 others	41/100
3rd	WeGene 2014, Shenzhen (China), Series B	Genetic testing solution	-	K2, Ameba Capital & 1 others	28/100
4th	LeGENE 2012, Hong Kong (China), Unfunded	Provider of personal genetic services	-	-	25/100
5th	ProGene Molecular Diagnostic Center 2015, Tsim Sha Tsui (China), Unfunded	Provider of genetic screening and molecular diagnostics services	-	-	24/100
6th	MyGene 2014, Beijing (China), Unfunded	Provider of gene mapping technology platform	-	-	24/100
7th	HEAL 2005, Kowloon (China), Unfunded	Provider of DNA tests for family identification, infectious diseases, prenatal and predisposition genetic testings	-	-	24/100
8th	GeseDNA 2014, Beijing (China), Seed	Provider of gene detection and interpretation tool	-	Idaxiang	22/100
9th	1JKT 2014, Shenzhen (China), Seed	Online platform offering appointment booking services for genetic tests	-	CZ Capital	22/100
10th	Biorna Quantics 2015, Hong Kong (China), Deadpooled	Quantified self for personalized health & wellness recommendations	-	-	21/100